“Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy”, FE, vol. 23, no. 1, Feb. 2022, doi: 10.7175/fe.v23i1.1510.